10% CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 7, 2016Premier Biomedical Inc • March 11th, 2016 • Biological products, (no disgnostic substances) • New York
THIS 10% CONVERTIBLE PROMISSORY NOTE is one of a series of duly authorized and validly issued 10% Convertible Promissory Notes of Premier Biomedical Inc. (the "Company"), having its principal place of business at P.O. Box 31374, El Paso, TX 79930, designated as its 10% Convertible Notes due December 7, 2016 (this Note, the "Note" and, collectively with the other Notes of such series, the "Notes").
FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 11th, 2016 • Premier Biomedical Inc • Biological products, (no disgnostic substances)
This First Amendment to Securities Purchase Agreement (this "Amendment") is entered into on February 22, 2016 by and between Premier Biomedical, Inc., a Nevada corporation (the "Company") and Redwood Management, LLC (the "Purchaser").
SECOND AMENDMENT TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 11th, 2016 • Premier Biomedical Inc • Biological products, (no disgnostic substances)
This Second Amendment to Securities Purchase Agreement (this "Amendment") is entered into on March 7, 2016 by and between Premier Biomedical, Inc., a Nevada corporation (the "Company") and Redwood Management, LLC (the "Purchaser").
